Topical Cyclosporine and Disease Progression

Phase 4CompletedNCT00567983

Innovative Medical80 enrolled

Overview

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Mild to Moderate dry eye symptoms Exclusion Criteria: * Current use of Restasis

Lakeside Eye Clinic

Chicago, Illinois, United States

Disease Severity

Time frame: 1 yr

Staining

Time frame: 1 yr

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.